849776-05-2 Usage
Uses
Used in Pharmaceutical Industry:
Methanesulfonic acid, trifluoro-, 4-[(1R)-1-methyl-2-[(methylsulfonyl)amino]-2-oxoethyl]phenyl ester is used as a prodrug for targeting specific sites in biological systems, making it a promising candidate for the development of new pharmaceuticals.
Used in Agrochemical Industry:
Methanesulfonic acid, trifluoro-,
4-[(1R)-1-methyl-2-[(methylsulfonyl)amino]-2-oxoethyl]phenyl ester is also used in agrochemicals, where it can act as a prodrug to target specific pests or diseases, providing an effective and selective method for pest control and crop protection.
Used in Medicinal Chemistry Research:
Methanesulfonic acid, trifluoro-, 4-[(1R)-1-methyl-2-[(methylsulfonyl)amino]-2-oxoethyl]phenyl ester serves as a valuable building block for medicinal chemistry research, aiding in the design and synthesis of new drugs and therapeutic agents.
Used in Drug Discovery:
As a key component in drug discovery, Methanesulfonic acid, trifluoro-,
4-[(1R)-1-methyl-2-[(methylsulfonyl)amino]-2-oxoethyl]phenyl ester contributes to the identification and development of novel drug candidates with potential therapeutic applications in various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 849776-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,7,7 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 849776-05:
(8*8)+(7*4)+(6*9)+(5*7)+(4*7)+(3*6)+(2*0)+(1*5)=232
232 % 10 = 2
So 849776-05-2 is a valid CAS Registry Number.
849776-05-2Relevant academic research and scientific papers
2-PHENYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page/Page column 15, (2008/06/13)
4-(trifluoromethanesulfonyloxyphenyl)propionic acid derivatives and pharmaceutical composition containing such compounds are useful in inhibiting the chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8)
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach
Aureli, Loretta,Cruciani, Gabriele,Cesta, Maria Candida,Anacardio, Roberto,De Simone, Lucio,Moriconi, Alessio
, p. 2469 - 2479 (2007/10/03)
A novel class of 2-(R)-phenylpropionamides has been recently reported to inhibit in vitro and in vivo interleukin-8 (CXCL8)-induced biological activities. These CXCL8 inhibitors are derivatives of phenylpropionic nonsteroidal antiinflammatory drugs (NSAID
